Nanoform Cardiovascular Therapeutics competitive analysis

Explore Nanoform Cardiovascular Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 10, 2026
Patent NumberPublication DateTitleTotal Oppositions
Sep 27, 2017Nanostructured Aprepitant Compositions, Process For The Preparation Thereof And Pharmaceutical Compositions Containing Them1

Latest PTAB cases involving Nanoform Cardiovascular Therapeutics

Discover the latest PTAB cases involving Nanoform Cardiovascular Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Nanoform Cardiovascular Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NANOFORM CARDIOVASCULAR THERAPEUTICS - 1 - -
ALKERMES PHARMA IRELAND61812